M. Trew

Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans

S. Glegg, B. Le Foll, N. Fairbairn, 2021, CMAJ open.

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline

B. Le Foll, E. Oviedo-Joekes, N. Fairbairn, 2019, Canadian Medical Association Journal.

NeuroAIDS: a watershed for mental health and nervous system disorders.

C. Power, F. Noorbakhsh, J. McCombe, 2009, Journal of psychiatry & neuroscience : JPN.

Depression Outcomes in Adults Attending Family Practice Were Not Improved by Screening, Stepped-Care, or Online CBT during a 12-Week Study when Compared to Controls in a Randomized Trial

Deena M Hamza, Ivor Cribben, P. Silverstone, 2017, Front. Psychiatry.

Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

M. Hayden, O. Suchowersky, J. Theilmann, 1992, American journal of medical genetics.

Medical Assistance in Dying (MAiD) for Persons Whose Sole Underlying Medical Condition is a Mental Disorder: Challenges and Considerations

D. Stewart, D. Godkin, Francine Knoops, 2021, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Virtual Overdose Response for People Who Use Opioids Alone: Protocol for a Feasibility and Clinical Trial Study

S. Ghosh, K. Rittenbach, M. Trew, 2020, JMIR research protocols.

Referrals for Movement Disorder Surgery: Under-Representation of Females and Reasons for Refusal

A. Haffenden, S. Longman, M. Setiawan, 2006, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Multidisciplinary approach to management of a hereditary neurodegenerative disorder: Huntington disease.

O. Suchowersky, M. Klimek, M. Trew, 1997, Axone.